DK664888A - Cyclooctanforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents

Cyclooctanforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse

Info

Publication number
DK664888A
DK664888A DK664888A DK664888A DK664888A DK 664888 A DK664888 A DK 664888A DK 664888 A DK664888 A DK 664888A DK 664888 A DK664888 A DK 664888A DK 664888 A DK664888 A DK 664888A
Authority
DK
Denmark
Prior art keywords
compound
hydroxy
cyclooctan
preparing
procedure
Prior art date
Application number
DK664888A
Other languages
English (en)
Other versions
DK664888D0 (da
Inventor
Raymond Baker
William R Carling
Kim James
Paul D Leeson
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of DK664888D0 publication Critical patent/DK664888D0/da
Publication of DK664888A publication Critical patent/DK664888A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK664888A 1987-11-30 1988-11-29 Cyclooctanforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse DK664888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878727989A GB8727989D0 (en) 1987-11-30 1987-11-30 Therapeutic agents

Publications (2)

Publication Number Publication Date
DK664888D0 DK664888D0 (da) 1988-11-29
DK664888A true DK664888A (da) 1989-07-20

Family

ID=10627761

Family Applications (1)

Application Number Title Priority Date Filing Date
DK664888A DK664888A (da) 1987-11-30 1988-11-29 Cyclooctanforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse

Country Status (8)

Country Link
US (1) US4927819A (da)
EP (1) EP0319073B1 (da)
JP (1) JP2791069B2 (da)
AT (1) ATE126801T1 (da)
CA (1) CA1336514C (da)
DE (1) DE3854343T2 (da)
DK (1) DK664888A (da)
GB (1) GB8727989D0 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU639722B2 (en) * 1989-10-27 1993-08-05 Astra Aktiebolag Use of arylalkylamides in the treatment of neurodegenerative diseases
GB9002834D0 (en) * 1990-02-08 1990-04-04 Ici America Inc Compounds
WO2010028213A2 (en) * 2008-09-05 2010-03-11 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds
US9114135B2 (en) 2010-08-24 2015-08-25 Sgc Pharma Inc. Salt compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7007464A (da) * 1969-05-30 1970-12-02
US4414154A (en) * 1977-09-19 1983-11-08 Merck & Co. Inc. Dibenzo[a,d]cycloocten-5,12-imines
NL7808848A (nl) * 1977-09-19 1979-03-21 Merck & Co Inc Dibenzoa.dcyclo-octeen-5.12-(en 6.12)-iminen.
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
US4927819A (en) 1990-05-22
DK664888D0 (da) 1988-11-29
EP0319073A2 (en) 1989-06-07
ATE126801T1 (de) 1995-09-15
JP2791069B2 (ja) 1998-08-27
JPH01186890A (ja) 1989-07-26
CA1336514C (en) 1995-08-01
EP0319073A3 (en) 1990-12-19
DE3854343D1 (de) 1995-09-28
DE3854343T2 (de) 1996-03-28
GB8727989D0 (en) 1988-01-06
EP0319073B1 (en) 1995-08-23

Similar Documents

Publication Publication Date Title
DE3263734D1 (en) Derivatives of 1-aryl-2-aminomethyl-cyclopropane-carboxamides (z), their preparation and their use as medicines in the treatment of disorders of the central nervous system
PT87700A (pt) Process for the preparation of a new pyrazolopyridine compound
RU2088589C1 (en) Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
EP1090908A3 (en) Cyclobutane derivatives as inhibitors of protein farnesyltransferase
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
MY129425A (en) Indole derivatives useful a.o. for the treatment of osteoporosis
EP0303507A3 (en) Indole derivatives
IL111275A (en) Derivatives of 6-demethylgalanthamine, their mono-and di-esters and pharmaceutical compositions containing them
PL339143A1 (en) Tetrahydro-gamma-carbolynes
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
NZ234501A (en) Hemoregulatory peptides and pharmaceutical compositions containing them
DK664888D0 (da) Cyclooctanforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
EP0521393A3 (en) Diclofenac salt, a method for the preparation thereof and pharmaceutical compositions containing it
DK0648762T3 (da) Bicykliske forbindelser som excitatoriske aminosyrereceptorantagonister
EP0339600A3 (en) Polycyclic amine derivatives useful as cerebrovascular agents
DE69822937D1 (de) Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen
EP0130069A3 (en) Hexahydropyrrolo (2,1-a) isoquinoline derivatives
HUT40110A (en) Process for preparing indole derivatives
NO981051L (no) Peptidderivater
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
ES8305350A1 (es) "un procedimiento para preparar derivados de dialcohilpirazol".
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment